Mostrar el registro sencillo del ítem

Bases genéticas y moleculares de la preeclampsia

dc.contributor.authorSerrano Díaz, Norma Ceciliaspa
dc.contributor.authorPáez Leal, María Carolinaspa
dc.contributor.authorMartínez Linares, María Paulaspa
dc.contributor.authorCasas Romero, Juan Pablospa
dc.contributor.authorGil Urbano, Lauraspa
dc.contributor.authorNavarro Mancilla, Álvaro Andrésspa
dc.date.accessioned2020-10-27T14:22:22Z
dc.date.available2020-10-27T14:22:22Z
dc.date.issued2002-12-09
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10532
dc.description.abstractLa preeclampsia es una enfermedad compleja, exclusiva de la gestación humana y responsables de una alta morbimortalidad perinatal. Ha sido denominada la enfermedad de las múltiples teorÍas, en la cual tanto factores medioambientales como genéticos se han asociado al desarrollo de la misma. para la identificación de los genes candidatos asociados con la PE, se han empleado dos tipos de metodologÍa, los estudios de asociación y los estudios de ligamiento.[Serrano NC, Páes MC, MartÍnez MP, Casas JP, Gil L, Nvarro AA. Bases genéticas y moleculares de la preeclampsia. MedUNAB 2002; 5(15):185-94].Palabras clave: Genética, preeclampsia, polimorfismos, estudios de ligamiento, estudios de asociación, metileneterahidrofolato reductasa, lipoprotein lipasa, óxidonitrico sintasa endotelial, factor V de Leiden, angiotesinógeno, HLA-G, y factor denecrosis tumoral alfa.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/275/258
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/275
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 5 Núm. 15 (2002): Preeclampsia, Escorpionismo, Disfunción eréctil, Psicofarmacología; 185-194
dc.subjectCiencias de la salud
dc.subjectMedicina
dc.subjectCiencias médicas
dc.subjectCiencias biomédicas
dc.subjectCiencias de la vida
dc.subjectInnovaciones en salud
dc.subjectInvestigaciones
dc.titleBases genéticas y moleculares de la preeclampsia
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programPregrado Medicina
dc.type.driverinfo:eu-repo/semantics/article
dc.type.localArtículospa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.subject.keywordsHealth Scienceseng
dc.subject.keywordsMedicineeng
dc.subject.keywordsMedical Scienceseng
dc.subject.keywordsBiomedical Scienceseng
dc.subject.keywordsLife Scienceseng
dc.subject.keywordsInnovations in healtheng
dc.subject.keywordsResearcheng
dc.subject.keywordsGenetics
dc.subject.keywordsPreeclampsia
dc.subject.keywordsPolymorphisms
dc.subject.keywordsLinkage studies
dc.subject.keywordsAssociation studies
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.relation.referenceslópez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: fromepidemiological observations to molecular mechanism. Braz JMed Biol Res: 2001;10: 1227-35.
dc.relation.referencesReport of the National High Blood Pressure Education ProgramWorking Group on High Blood Pressure in Pregnancy. Am JObstet Gynecol 2000;183 :S1-S22
dc.relation.referencesGómez P. Ruiz N, Pulido J. Mortalidad materna en el InstitutoMaterno Infantil de Santafé de Bogotá D.C. 1985-1989. RevCol Obst Ginecol 1993;44:39-47
dc.relation.referencesEncuesta Demográfica y de Salud Familiar (ENDES 2000).Disponible en: URL:http://www.minsa.gov.pe/enfermedad/salud-materna.htm
dc.relation.referencesDekker GA, Sibai BM. Etiology and patogenesis of preeclampsia:current concepts. Am J Obstet Gynecol 1998;179:1359-75
dc.relation.referencesAtallah AN, Hofmeyr GJ, Duley L. Calcium supplementationduring pregnancy for preventing hypertensive disorders andrelated problems. Cochrane Library number: CD001059
dc.relation.referencesDekker G, Sibai B. Primary, secondary and tertiary preventionof pre-eclampsia. Lancet 2001;357:209-15
dc.relation.referencesRoberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6
dc.relation.referencesGraves JV. Genomic imprinting, development and disease: ispre-eclampsia caused by a maternally imprinted gene? ReprodFertil Dev 1998;10:23-9
dc.relation.referencesRos HS; Lichtenstein P, Lipworth L, et al. Genetic effects on theliability of developing pre-eclampsia and gestacionalhypertension. Am J Med Genet 2000;91:256-60
dc.relation.referencesRisch NJ. Searching for genetic determinants in the newmillennium. Naturez 2000;405(15):847-56
dc.relation.referencesMoses E, Lade J, Guo G, et al. A genome scan in families fromAustralia and New Zealand confirms the presence of a maternalsusceptibility locus for Pre-eclampsia, on chromosome 2. Am.J. Hum. Genet. 2000;67:1581-5
dc.relation.referencesArngrímsson R, Sigurardóttir S, Frigge ML, et al. A genome-widescan reveals a maternal susceptibility locus for pre-eclampsia onchromosome 2p13. Hum Mol Genet 1999;8:1799-1805
dc.relation.referencesHarrison GA, Humphrey KE, Jones N, et al. Aa genomewidelinkage study of preeclampsia/eclampsia reveals evidence fora candidate regios on 4q. Am J Hum Genet 1997;60:1158-67
dc.relation.referencesGuo GL, Lade JA, Wilton AN, et al. Genetic susceptibility to pre-eclampsia and chromosome 7q36. Hum Genet 1999;105:641-7.
dc.relation.referencesHirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. Acomprehensive review of genetic association studies. Genet Med2002:4(2):45-61
dc.relation.referencesCardon LR, Bell J. Association study designs for complexdiseases. Nature Reviews Genetics 2001;2:91-99
dc.relation.referencesPritchard JK, Rosenberg NA. Use of unlinked genetic markersto detect population stratification in association studies. Am JHum Genet 1999;65:220-8
dc.relation.referencesDevlin B, Roeder K. Genomic control for association studies.Biometrics 1999;55:997-1004
dc.relation.referencesReich DE, Goldtein DB. Detecting association in case-controlstudy while correcting for population stratification. GenetEpidemiol 2001;20:4-16
dc.relation.referencesRefsum H, Veland PM, Nygard O. Homocysteine andcardiovascular disease. Annu Rev Med 1998;49:31-62
dc.relation.referencesGoddijn-Wessel TAW, Wouters M, Molen van der EF.Hyperhomocysteinemeia risk factor for placental abruption orinfarction. Eur Obstet Gynecol Reprod Biol 1996;66:23-9
dc.relation.referencesWouters MGAJ, Boers GHJ, Blom HJ et al.Hyperhomocysteinemia a risk factor in women with unexplainedrecurrent early pregnancy loss. Fertil Steril 1993;60:820-5
dc.relation.referencesJara-Prado A, Santa María A. Homocisteina: un nuevo factorde riesgo para enfermedades vasculares. Arch Neurocien2002;7(1):43-50
dc.relation.referencesRajkovic A, Catalano PM, Malinow MR. Elevated homcysteinelevels with Preeclampsia. Obstet Gynecol 1997;90:168-71
dc.relation.referencesRajkovic A, Mahomed K, Malinow MR et al. Plasmahomocysteine concentrations in eclamptic and preeclampticAfrican women postpartum. Obstet Gynecol 1999;94:355-60
dc.relation.referencesFrosst P, Blom HJ, Milos R et al. A candidate genetic risk factorfor vascular disease: a common mutation in methylen-etetrahydrofolate reductase. Nat Genet 1995;10:111-3
dc.relation.referencesvan der Put NM, Grabreels F, Stevens EM. A second commonmutation in the methylenetetrahydrofolate reductase gene: unadditional risk factor for neural tube defects? Am J Hum Gener1998;62:1044-51
dc.relation.referencesPowers RW, Evans RW, Majors AK et al. Plasma homocysteineconcentrations is increased in preeclamptic and is associatedwith evidence of endothelial activation. Am J Obstet Gynecol1999;179:1605-11
dc.relation.referencesSohda S, Arinami T, Hamada H et al. Methylenetetrahydrofolatereductase polymorphisms and preeclampsia. J Med Genet1997;34:526-36
dc.relation.referencesGrandone E, Margaglione M, Colarzzo D et al. Factor vV Leiden,C677T methylenetetrahydrofolate reductase polymorphisms andgenetic susceptibility to preeclampsia. Thromb Haemost1997;77:1052-4
dc.relation.referencesNagy B, Toth T, Rigo J et al. Detection of factor V leiden mutationin sever preeclampsia. Hungarian women. Clin Genet1998;53:478-81
dc.relation.referencesKaisser T, Brennecke SP, Moses EK. Methylenetetrahydrofolatereductase polymorphisms are not a risk factor for Preeclampsia– Eclampsia in Australian women. Gynecol Obstet Invest2000;50:100-2
dc.relation.referencesLachmeijer Am, Arngrímsson R, Bastiaans EJ et al. Mutationsin the gene for methylenetetrahydrofolate reductase, hocysteinelevels, and vitamin status in women with a history ofpreeclampsia. Am J Obstet Gynecol 2001;184:394-402
dc.relation.referencesPowers RW, Minich LA, Lykins DL et al. Methylen-etetrahydrofolatereductase polymorphisms, float and susceptibility to preeclampsia.J Soc Gynecol Invest 1999;6:74-9
dc.relation.referencesChikos AB, Moodley J, Pegoraro RJ et al. 5,10 methylen-etetrahydrofolate polymorphisms in black South African womenwith preeclampsia. Br Obstet Gynaecol 1999;106:1219-20
dc.relation.referencesZousterzeel PLM, Visser W, Blom H et al. Methylen-etetrahydrofolate reductase polymorphisms in preeclampsia andHELLP syndrome. Hypertension Preg 2000;19(3):299-307
dc.relation.referencesBertina R, Koelman B, Koster T et al. Mutation in bloodcoagulation factor V associated with resistance to activatedprotein C. Nature 1994;369:64-7
dc.relation.referencesDahlback B. Inherited resistance to activated protein C, a majorcause of venous thrombosis is due to amutation in the factor Vgene. Haemostasis 1994;24:139-51
dc.relation.referencesBonnar J. Venous thromboembolism and pregnancy. Clin ObstetGynecol 1981;30:455-73
dc.relation.referencesDizon-Townson D, Nelson L, Easton K et al. The factor V Leidenmutation may predispose women to severe preeclampsia. AmJ Obstet Gynecol 1996;175:902-5
dc.relation.referencesD’Elia AV, Driul L, Giacomello R, et al. Frequency of factor V,prothrombin and methylenetetrahydrofolate reductase genevariants in preeclampsia. Gynecol Obstet Invest 2002;53(2):84-7
dc.relation.referencesWatanabe H, Hamada H, Yamada N, et al. Association analysisof nine missense polymorphisms in the coagulation factor V genewith severe preeclampsia in pregnant Japanese women. J HumGenet 2002;47(3):131-5
dc.relation.referencesCurrie L, Peek M, McNiven M, Prosser I, Mansour J, RidgwayJ. Is there an increased maternal-infant prevalence of Factor VLeiden in association with severe pre-eclampsia?BJOG 2002 Feb;109(2):191-6
dc.relation.referencesvan Pampus MG, Wolf H, Koopman MM, van den Ende A, BullerHR, Reitsma PH. Prothrombin 20210 G: a mutation and FactorV Leiden mutation in women with a history of severepreeclampsia and (H)ELLP syndrome. Hypertens Pregnancy2001;20(3):291-8
dc.relation.referencesLivingston JC, Barton JR, Park V, Haddad B, Phillips O, SibaiBM. Maternal and fetal inherited thrombophilias are not relatedto the development of severe preeclampsia. Am J ObstetGynecol 2001 Jul;185(1):153-7
dc.relation.referencesKim YJ, Williamson RA, Murray JC, et al. Genetic susceptibilityto preeclampsia: roles of cytosineto-thymine substitution atnucleotide 677 of the gene for methylenetetrahydrofolatereductase, 68-base pair insertion at nucleotide 844 of the genefor cystathionine beta-synthase, and factor V Leiden mutation.Am J Obstet Gynecol 2001 May;184(6):1211-7
dc.relation.referencesRigo J Jr, Nagy B, Fintor L, et al. Maternal and neonatal outcomeof preeclamptic pregnancies: the potential roles of factor VLeiden mutation and 5,10 methylenetetrahydrofolate reductase.Hypertens Pregnancy 2000;19(2):163-72
dc.relation.referencesKobashi G, Yamada H, Asano T, et al. The factor V Leiden mutationis not a common cause of pregnancy-induced hypertension inJapan. Semin Thromb Hemost 1999;25(5):487-9
dc.relation.referencesDe Groot CJ, Bloemenkamp KW, Duvekot EJ, et al.Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999 Oct;181(4):975-80
dc.relation.referencesO’Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, MorrisNH. Factor V Leiden and thermolabile methylenetetrahydrofolatereductase gene variants in an East Anglian preeclampsia cohort.Hypertension 1999 Jun;33(6):1338-41
dc.relation.referencesNagy B, Toth T, Rigo J Jr, Karadi I, Romics L, Papp Z. Detectionof factor V Leiden mutation in severe pre-eclamptic Hungarianwomen. Clin Genet 1998 Jun;53(6):478-81
dc.relation.referencesGrandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden,C > T MTHFR polymorphism and genetic susceptibility topreeclampsia. Thromb Haemost 1997 Jun;77(6):1052-4
dc.relation.referencesDizon-Townson DS, Nelson LM, Easton K, Ward K. The factor VLeiden mutation may predispose women to severe preeclampsia.Am J Obstet Gynecol 1996 Oct;175(4 Pt 1):902-5
dc.relation.referencesCampbell D. Circulating and tissue angiotensin systems. J ClinInvest 1987;79:1-6.
dc.relation.referencesPowell J, Clozel J-P, Muller R et al. Inhibitors of angotensin-converting enzyme prevent myointimal proliferation aftervascular injury. Science 1989;245:186-8
dc.relation.referencesWard K, Hata A, Jeunemaitre X et al. A molecular variant ofangiotensinogen associated with preeclampsia. Nature Genetics1993:4;59-61
dc.relation.referencesKobashi G. A case – control study of pregnancy – inducehypertension with a genetic predisposition: Asociation of amolecular variant of AGT in the Japanese women. Hok Ig Zasshi1995;70:649-57
dc.relation.referencesKobashi G, Shido K, Hata A et al. Multivariate analysis of geneticand acquired factors; T235 variant of the angiotensinogen geneis a potent independent risk factor for preeclampsia. SeminThromb Hemost 2001;27(2):143-7
dc.relation.referencesSuzuki Y, Tanemura M, Murakami I et al. Is angiotensinogengene polymorphism associated with hipertensión in pregnancy?Hypertens Pregnancy 1999;18:261-71
dc.relation.referencesGuo G, Wilton AN, Fu Y et al. Angiotensinogen gene variationin apopulation cas-control study of preeclampsia/eclampsia inAustralians and Chinese. Electrophoresis 1997;18:1646-9
dc.relation.referencesMorgan L, Baker P, Pipkin FB et al. Pre-eclampsia and theangiotensinogen gene. BIOG 1995;102:489-90
dc.relation.referencesInoue F, Nakajima T, Williams C et al. A nucleotide substitutionin the promoter of human AGT is associated with essentialhypertension and effects basal transcriptions. J Clin Invest1997;99:1786-97
dc.relation.referencesMorgan T, Craven C, Nelson L. Angiotensinogen T235expression is elevated in decidual spiral arteries. J Clin Invest1997;100:1406-15
dc.relation.referencesMorgan T, Ward K. New Insights into the genetics ofpreeclampsia. Seminars in Perinatology 1999;23(1):14-23
dc.relation.referencesWilliams RR, Hunt SC, Hopkins PN et al. Tabulations andexpectations regarding the genetics human hypertension. KidneyInt 1994;45:s57-s64
dc.relation.referencesKastelein JIP, Groenemeyer BE, Hallman DM et al. The Asn9variant of lipoprotein lipase is associated with the – 93G promotormutation and an increased risk of coronary artery disease
dc.relation.referencesWalsh S. Lipid peroxidation in pregnancy. Hypertens Preg1994;13:1-25
dc.relation.referencesKim YJ, Williamson KC, Smith JL et al. Lipoprotein lipase genemutations and the genetic susceptibility of preeclampsia.Hypertension 2001;38:992-6
dc.relation.referencesVanWijk MJ, Kublickiene K, Boer K et al. Vascular function inpreeclampsia. Cardiovascular Research 2000;47:38-48
dc.relation.referencesMeekins JW, Pijnenborg R, Anssens M et al. A study of placentalbed spiral arteries and trophoblast invasion in normal and sever pre-eclamptic pregnancies. Br J Obstet Gyanecol 1994;101:669-74
dc.relation.referencesHumphrey KE, Harrison GA, Cooper DW et al. HLA-G deletionpolymorphisms and preeclampsia/eclampsia. Br J ObstetGynaecol 1995;102(9):707-10
dc.relation.referencesBermingham J, Jenkins D, Mc Carthy T et al. Genetic analysisof insulin-like growth factor II and HLA-G in preeclampsia.Biochem Soc Trans 2000:28(2):215-9
dc.relation.referencesO’Brien M, McCarthy T, Jenkins D et al. Altered HLA-Gtranscription in pre-eclampsia is associated with allele specificinheritance: possible role of the HLA-G gene in susceptibility tothe disease. Cell Mol Life Sci 2001 58(12-13):1943-9
dc.relation.referencesHara N, Fujii T, Yamashita T, Kozuma S et al. Altered expressionof human leukocyte antigen G (HLA-G) on extravilloustrophoblasts in preeclampsia: immunohistological demonstration
dc.relation.referencesGoldman-Wohl DS, Ariel I, Greenfield C et al. Lack of human leuko-cyte antigen-G expression in extravillous trophoblast is associatedwith pre-eclampsia. Mol Hum Reprod 2000 Jan;6(1):88-95
dc.relation.referenceserranova PF, Huntor VJ, Roby KF. Tumor necrosis factor-alpha infemale reproductive tract. Proc Soc Exp Biol Med 1995;209:325-42
dc.relation.referencesHun JS, Chen HL, Miller L et al. Tumor necrosis factor: pivotalcomponents of pregnancy? Biol Reprod 1996;4554-62
dc.relation.referencesWheler T, Evans PW, Anthony FW et al. Relationship betweenmaternal serum vascular endothelia growth factor concentrationsin early pregnancy and fetal and placental growth. Hum Reprod1999;14:1619-23
dc.relation.referencesNevils B, Conrad K, Increased circulating levels of TNF-a inpreeclampsia: Aposible role for cytokines in the pathogenesisof the disease. J Gynecol Invest 1995;2:311
dc.relation.referencesConrad KP, Benyo DE. Placental cytokines and the pathogenesisof preeclampsia. Am J Reprod Immunol 1997;.37:240-9
dc.relation.referencesLi K, Wang L, Tong X. Study on tumor necrosis factor andpathogenesis of pregnancy induced hypertension. ZhonghuaFu Chan Ke Za Zhi 1999;34(6):339-41. Medline
dc.relation.referencesDekker GA, Sibai BM. Etiology and pathogenensis ofpreeclampsia:Current concepts. Am J Obstet Gynecol1998;179:1359-75
dc.relation.referencesWilliams MA, Farrand A, Mittendorf R et al. Maternal secondtrimester serum tumor necrosis factor-alpha-soluble receptorp55 (sTNFp55) and subsequent risk of preeclampsia. Am JEpidemiol 1999 Feb 15;149(4):323-9
dc.relation.referencesRinehart BK, Terrone DA, Lagoo-Deenadayalan S et al.Expression of the placental cytokines tumor necrosis factoralpha, interleukin 1beta, and interleukin 10 is increased inpreeclampsia. Am J Obstet Gynecol 1999;181(4):915-20
dc.relation.referencesDizon-Townson DS, Major H, Ward K. A promoter mutation inthe tumor necrosis factor alpha gene is not associated withpreeclampsia. Reprod Immunol 1998 Apr;38(1):55-61
dc.relation.referencesLivingston JC, Park V, Barton JR,Lack of association of severepreeclampsia with maternal and fetal mutant alleles for tumor necrosisfactor alpha and lymphotoxin alpha genes and plasma tumor necrosisfactor alpha levels. Am J Obstet Gynecol 2001;184(6):1273-7
dc.relation.referencesLachmeijer AM, Crusius JB, Pals G et al. Polymorphisms in thetumor necrosis factor and lymphotoxin-alpha gene region andpreeclampsia. Obstet Gynecol 2001;98(4):612-9
dc.relation.referencesHeiskanen J, Romppanen EL, Hiltunen M. Polymorphism in thetumor necrosis factor-alpha gene in women with preeclampsia.J Assist Reprod Genet 2002;19(5):220-3
dc.relation.referencesPalmer RM, Ferrige AG, Mocada S. Nitric oxide release accountsfor the biological activity of endothelium-derived relaxing factor.Nature1987;327:524-26
dc.relation.referencesSladek SM, Magness RR, Conrad KP. Nitric oxide andpregnancy. Am J Physiol 1997;272:441-463
dc.relation.referencesDavidge ST, Stranko CP, Roberts JM. Urine but not plasma nitricoxide metabolites are decreased in women with preeclampsia.Am J Obstet Gynecol 1996;174:1008-1013
dc.relation.referencesNobunaga T, Tokugawa Y, Hashimoto K, et al. Plasma nitricoxide levels in pregnant patients with preeclampsia and essentialhypertension. Gynecol Obstet Invest 1996;41:189-193
dc.relation.referencesDi Ioro R, Marinoni E, Emiliani S, et al. Nitric oxide inpreeclampsia: lack of evidence for decreases production. Eur JObstet Gynecol Reprod Biol 1998;76:65-70
dc.relation.referencesMorris NH, Eaton BM, Dekker G. Nitric oxide, the endotheliumpregnancy and pre-eclampsia. Br J Obstet Gynecol 1996;103:4-15
dc.relation.referencesHingorani AD, Liang CF, Fatibene J, et al. A common variant ofthe endothelial nitric oxide synthase (Glu298Asp) is a major riskfactor for coronary artery disease in the UK. Circulation1999;100:1515-20
dc.relation.referencesYoshimura M. A missense Glu298Asp variant in the endothelialnitric oxide synthase gene is associated with coronary spasmin the Japanese. Hum Genet 1998;103:65-69
dc.relation.referencesYoshimura M et al. Genetic risk factor for coronary artery spasm:significance of endothelial nitric oxide synthase gene T786Cand missense Glu298Asp variants. J Invest Med 2000;48:367-74.
dc.relation.referencesMiyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxidesynthase gene is positively associated with essentialhypertension. Hypertension 1998;32:3-8
dc.relation.referencesShoji M et al. Positive association of endothelial nitric oxidesynthase gene polymorphism with hypertension in northernJapan. Life Sci 2000;66:2557-62
dc.relation.referencesShimasaki Y, et al. Association of the missense Glu298Aspvariant of the nitric oxide synthase gene with myocardialinfarction. J Am Coll Cardiol 1999;31:1506-10
dc.relation.referencesTeasuro M, Thompson WC, Rogliani P et al. Intracellularprocessing of endothelial nitric oxide synthase isoformsassociated with differences in severity of cardiopulmonarydiseases: cleavage of proteins with aspartate vs. glutamate atposition 298. Proc Natl Acad Sci USA 2000 97;2832-35
dc.relation.referencesSavvidou MD, Vallance PJ, Nicolaides KH et al. Endothelialnitric oxide synthase gene polymorphism and maternal vascularadaptation to pregnancy. Hypertension 2001 Dec 1;38(6):1289-93
dc.relation.referencesKobashi G, Yamada H, Ohta K et al. Endothelial nitric oxidesynthase gene (NOS3) variant and hypertension in pregnancy.Am J Med Genet 2001 Oct 15;103(3):241-4
dc.relation.referencesBashford MT, Hefler LA, Vertrees TW et al. Angiotensinogenand endothelial nitric oxide synthase gene polymorphismsamong Hispanic patients with preeclampsia. Am J ObstetGynecol 2001 Jun;184(7):1345-50; discussion 1350-1
dc.contributor.cvlacSerrano Díaz, Norma Cecilia [0000066613]
dc.contributor.cvlacPáez Leal, María Carolina [0000066656]
dc.contributor.cvlacCasas Romero, Juan Pablo [0000018562]
dc.contributor.googlescholarPáez Leal, María Carolina [BAPR3-cAAAAJ]
dc.contributor.orcidSerrano Díaz, Norma Cecilia [0000-0003-3532-2002]
dc.contributor.orcidPáez Leal, María Carolina [0000-0002-0310-0125]
dc.contributor.scopusSerrano Díaz, Norma Cecilia [7003706613]
dc.contributor.scopusPáez Leal, María Carolina [12243485600]
dc.contributor.researchgatePáez Leal, María Carolina [profile/Maria_Paez-Leal]
dc.subject.lembGenética humana
dc.subject.lembBiología
dc.subject.lembCiencias de la vida
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.description.abstractenglishPreeclampsia is a complex disease, exclusive of human pregnancy and responsible for high perinatal morbidity and mortality. It has been called the disease of multiple theories, in which both environmental and genetic factors have been associated with its development. For the identification of candidate genes associated with PE, two types of methodology have been used, association studies and linkage studies. This article explains the rationale for both studies and reviews the main candidate genes within the pathophysiology of the disease, including those that code for the enzymes methylene tetrahydrofolate reductase, lipoprotein lipase and endothelial nitric oxide synthase; factor V Leiden, angiotensinogen, HLA-G, and necrotumor factor alphaeng
dc.subject.proposalGenética
dc.subject.proposalPreeclampsia
dc.subject.proposalPolimorfismos
dc.subject.proposalEstudios de ligamiento
dc.subject.proposalEstudios de asociación
dc.identifier.doi10.29375/01237047.275
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.contributor.researchgroupGrupo de Estudio Genético de Enfermedades Complejasspa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa


Ficheros en el ítem

Thumbnail
Nombre:
2002_Bases_genéticas_y_molecul ...
Tamaño:
364.3Kb
Formato:
PDF
Descripción:
Articulo
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/2.5/co/